Please use this identifier to cite or link to this item:
Type: Artigo
Title: Employing Proteomics To Unravel The Molecular Effects Of Antipsychotics And Their Role In Schizophrenia
Author: Cassoli
Juliana S.; Guest
Paul C.; Santana
Aline G.; Martins-de-Souza
Abstract: Schizophrenia is an incurable neuropsychiatric disorder managed mostly by treatment of the patients with antipsychotics. However, the efficacy of these drugs has remained only low to moderate despite intensive research efforts since the early 1950s when chlorpromazine, the first antipsychotic, was synthesized. In addition, antipsychotic treatment can produce often undesired severe side effects in the patients and addressing these remains a large unmet clinical need. One of the reasons for the low effectiveness of these drugs is the limited knowledge about the molecular mechanisms of schizophrenia, which impairs the development of new and more effective treatments. Recently, proteomic studies of clinical and preclinical samples have identified changes in the levels of specific proteins in response to antipsychotic treatment, which have converged on molecular pathways such as cell communication and signaling, inflammation and cellular growth, and maintenance. The findings of these studies are summarized and discussed in this review and we suggest that this provides validation of proteomics as a useful tool for mining drug mechanisms of action and potentially for pinpointing novel molecular targets that may enable development of more effective medications.
Subject: Antipsychotics
Psychiatric Disorders
Editor: Wiley-V C H Verlag Gmbh
Citation: Proteomics Clinical Applications. Wiley-v C H Verlag Gmbh, v. 10, p. 442 - 455, 2016.
Rights: fechado
Identifier DOI: 10.1002/prca.201500109
Date Issue: 2016
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
000373947200013.pdf228.64 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.